Clinical cases of the treatment of metastatic colorectal cancer in Russia

Современная онкология

V V Shkuratova¹  O V Nekrasova¹  A I Hasanova²  R R Minnabetdinova²  V E Goldberg³  Yu V Belevich³  E A Dudnikova³  T L Kravchuk³  N O Popova³  E I Simolina³  V V Vysockaya³ 

[1] Multidisciplinary Clinical Medical Center “Medical city”;Republican Clinical Oncologic Dispensary;Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences;

关键词: colorectal cancer (crc);    targeted therapy;    regorafenib;   

DOI  :  

来源: DOAJ

【 摘 要 】

The article presents the clinical cases of the targeted therapy regorafenib in metastatic colorectal cancer (mCRC) in Russia. Russian oncologists’ experience has not only confirmed the results of international clinical trials, but also clearly demonstrated the possibility of regorafenib long-term administration on the back of high efficacy and manageable safety profile.

【 授权许可】

Unknown